quinazolines has been researched along with Erythrocytosis in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alcindor, T; Awan, A | 1 |
| Bernhardt, B; Peerschke, EI; Silver, RT; Varon, D; Weksler, BB; Yin, W | 1 |
| Petitt, RM; Petrone, ME; Silverstein, MN | 1 |
| Gilbert, HS | 1 |
2 review(s) available for quinazolines and Erythrocytosis
| Article | Year |
|---|---|
Anagrelide for control of thrombocythemia in polycythemia and other myeloproliferative disorders.
Topics: Fibrinolytic Agents; Humans; Polycythemia; Quinazolines; Thrombocytosis | 1997 |
Other secondary sequelae of treatments for myeloproliferative disorders.
Topics: Antineoplastic Agents; Fibrinolytic Agents; Humans; Hydroxyurea; Immunologic Factors; Interferon-alpha; Nucleic Acid Synthesis Inhibitors; Polycythemia; Quinazolines; Thrombocytosis | 2002 |
2 other study(ies) available for quinazolines and Erythrocytosis
| Article | Year |
|---|---|
Secondary polycythemia in a sarcoma patient: a commentary about cediranib.
Topics: Antineoplastic Agents; Humans; Lung Neoplasms; Male; Middle Aged; Polycythemia; Protein Kinase Inhibitors; Quinazolines; Sarcoma, Alveolar Soft Part | 2019 |
Examination of platelet function in whole blood under dynamic flow conditions with the cone and plate(let) analyzer: effect of erythrocytosis and thrombocytosis.
Topics: Benzamides; Blood Flow Velocity; Blood Platelets; Hematocrit; Humans; Imatinib Mesylate; Piperazines; Platelet Adhesiveness; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Count; Platelet Function Tests; Polycythemia; Pyrimidines; Quinazolines; Thrombocytosis; Time Factors | 2007 |